Page last updated: 2024-08-21

adamantane and transforming growth factor beta

adamantane has been researched along with transforming growth factor beta in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barry, MA; Blum, JS; Li, RH; Mikos, AG1
Gangadharan Komala, M; Gross, S; Panchapakesan, U; Pollock, C; Zaky, A1
Annunziata, P; Cioni, C; Corelli, F; Marotta, G; Mugnaini, C; Tassi, M1

Other Studies

3 other study(ies) available for adamantane and transforming growth factor beta

ArticleYear
An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2.
    Journal of cellular biochemistry, 2001, Volume: 80, Issue:4

    Topics: Adamantane; Alkaline Phosphatase; Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cattle; Cell Differentiation; Cell Line; Colorimetry; Dose-Response Relationship, Drug; Humans; Intestines; Luminescent Measurements; Mice; Osteoblasts; Phenotype; Recombinant Proteins; Sensitivity and Specificity; Spectrophotometry; Transforming Growth Factor beta; Up-Regulation

2001
Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Nephrology (Carlton, Vic.), 2016, Volume: 21, Issue:5

    Topics: Adamantane; Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fibronectins; Fibrosis; Glomerulonephritis; Hypertrophy; Insulin; Kidney; Male; Mice, Knockout; Nephritis, Interstitial; Nitric Oxide Synthase Type III; Phosphorylation; Signal Transduction; Smad2 Protein; Smad3 Protein; Streptozocin; Transcription Factor RelA; Transforming Growth Factor beta

2016
A Novel Highly Selective Cannabinoid CB2 Agonist Reduces in vitro Growth and TGF-beta Release of Human Glial Cell Tumors.
    Central nervous system agents in medicinal chemistry, 2019, Volume: 19, Issue:3

    Topics: Adamantane; Apoptosis; Cannabinoid Receptor Agonists; Cannabinoids; Cell Proliferation; Dose-Response Relationship, Drug; Glioma; Humans; Quinolones; Receptor, Cannabinoid, CB2; Transforming Growth Factor beta; Tumor Cells, Cultured

2019